{"id":1021841,"date":"2026-11-17T12:13:53","date_gmt":"2026-11-17T17:13:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/"},"modified":"2026-11-17T12:13:53","modified_gmt":"2026-11-17T17:13:53","slug":"orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/","title":{"rendered":"Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW HOPE, Pa., Nov.  17, 2026  (GLOBE NEWSWIRE) &#8212; Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (\u201cOrchestra BioMed\u201d or the \u201cCompany\u201d), a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companies, today announced that management will participate in the Piper Sandler 38<sup>th<\/sup> Annual Healthcare Conference being held December 1-3, 2026, in New York City. David Hochman, Chairman and Chief Executive Officer, will participate in a fireside chat hosted by Matthew O\u2019Brien, Managing Director, Senior Research Analyst at Piper Sandler on Wednesday, Dec. 2, 2026, at 9:00am ET. Management will also host one-on-one meetings with investors during the event.<\/p>\n<p align=\"justify\">A <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6ROYRBnu456sPRlDmszskuVnPH0fxNIPy2bb9oClBMLXGq1R-B2DZKWIslsp4gqlcG0vZPkOklaudh6KaXuh-2C8IPY0RB8Ecy-jo8ziYdrB1WKSL5D5Lj3l3u3i5re8DSUAubw4PvaEnpMiUY-Q0iqEaKqQLxchwoPRX-jf7sWMFsD16ocaK9fwSKWB79Kh\" rel=\"nofollow\" target=\"_blank\">live webcast<\/a> of the event will be accessible through Orchestra BioMed\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wOn6_VddWVjYeqypj8hJyD_w7DHGFng-zS5sLvSTK7kaNXjGUxVn9cDxohxr2utu0vBFBC7mVc0N6WewX3pCHhxqkpB0U4sDsiYLmUSzwynaTM4x6dfN9cDz-RJBtJ2f1guUDP8PYlMR3ywl13zy6w==\" rel=\"nofollow\" target=\"_blank\">Investor Relations website<\/a> and will be available for replay following the event.<\/p>\n<p align=\"justify\">\n        <strong>About Orchestra BioMed<\/strong>\n      <\/p>\n<p align=\"justify\">Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companies. The Company\u2019s two flagship product candidates, Atrioventricular Interval Modulation (AVIM) Therapy and Virtue<sup>\u00ae <\/sup>Sirolimus AngioInfusion\u2122 Balloon (Virtue SAB), are currently undergoing pivotal clinical trials for their lead indications, each representing multi-billion-dollar annual global market opportunities.<\/p>\n<p align=\"justify\">AVIM Therapy is a bioelectronic treatment for hypertension, the leading risk factor for death worldwide, and is designed to be delivered by a pacemaker and achieve immediate, substantial and sustained reductions in blood pressure in patients with hypertensive heart disease. The Company has a strategic collaboration with Medtronic (NYSE: MDT), one of the largest medical device companies in the world and the global leader in cardiac pacing therapies, for the development and commercialization of AVIM Therapy for the treatment of uncontrolled hypertension in pacemaker-indicated patients. AVIM Therapy has two FDA Breakthrough Device Designations. The BACKBEAT Trial evaluating AVIM Therapy has completed enrollment.<\/p>\n<p align=\"justify\">Virtue SAB is a first-of-its-kind, non-coated drug delivery AngioInfusion\u2122 balloon system designed to infuse a large liquid dose of proprietary extended-release formulation of sirolimus, SirolimusEFR\u2122, for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. Virtue SAB exceeded the published pharmacokinetics of leading limus drug-eluting stents and demonstrated positive three-year clinical data in coronary In-Stent Restenosis in the SABRE study, a multi-center prospective, independent core lab-adjudicated pilot clinical study of 50 patients conducted in Europe. Virtue SAB has been granted Breakthrough Device Designation by the FDA for the treatment of coronary in-stent restenosis, coronary small vessel disease and below-the-knee peripheral artery disease, in each case, within specified parameters. The Virtue Trial evaluating Virtue SAB for the treatment of coronary in-stent restenosis is currently enrolling patients.<\/p>\n<p align=\"justify\">\n        <strong>CAUTION: Investigational devices. Limited by United States law to investigational use.<\/strong>\n      <\/p>\n<p align=\"justify\">For further information about Orchestra BioMed, please visit www.orchestrabiomed.com, and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eQEPedNnLjh8RK0476_sUQ8uiSf6ArE9S20ZXIsuihWmWE2O1w7Knr42lbKYbKd1CrBIGXf5pjbXhYTyuXio7O9bpywdCvaju2o6AjvToZfCHepZICWYMDseehEAWoS7\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Silas Newcomb<br \/>Orchestra BioMed<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n8miEQayRWEnPiEPG04M4SyFx4nND2TbrXPvuDr5zAaXcc0JfqtnZ7RCxoWt6RKKKsRycLXDASZrcokSA5UNjFdiAPQdJ-39_9mNAKVKM4T-fqprl7U6s4NpKB00Bfg-\" rel=\"nofollow\" target=\"_blank\">snewcomb@orchestrabiomed.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Nina Premutico<br \/>Orchestra BioMed<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UpR6MXuwL7hyfRI5jCRL7YY0xK70XHVf4LTTX30Dii079istp3IxwtvIonp_omlM5addSPVnpF_D_dsswIF7Rxz8kFUe4rTpFaB3FuvchnXzNJ_IChlEkNQ2NUP4egjG\" rel=\"nofollow\" target=\"_blank\">npremutico@orchestrabiomed.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3ODUyOSM3OTY4MjM5IzIxOTQwMTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmRlNjExYjMtYzg4Ni00NzNhLThjN2MtMmQ4NTM2YWFmZGQ5LTEyMDU1NzItMjAyNi0xMS0xNy1lbg==\/tiny\/Orchestra-BioMed-Holdings-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW HOPE, Pa., Nov. 17, 2026 (GLOBE NEWSWIRE) &#8212; Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (\u201cOrchestra BioMed\u201d or the \u201cCompany\u201d), a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companies, today announced that management will participate in the Piper Sandler 38th Annual Healthcare Conference being held December 1-3, 2026, in New York City. David Hochman, Chairman and Chief Executive Officer, will participate in a fireside chat hosted by Matthew O\u2019Brien, Managing Director, Senior Research Analyst at Piper Sandler on Wednesday, Dec. 2, 2026, at 9:00am ET. Management will also host one-on-one meetings with investors during the event. A live webcast of the event will be accessible through Orchestra BioMed\u2019s Investor Relations website &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1021841","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW HOPE, Pa., Nov. 17, 2026 (GLOBE NEWSWIRE) &#8212; Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (\u201cOrchestra BioMed\u201d or the \u201cCompany\u201d), a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companies, today announced that management will participate in the Piper Sandler 38th Annual Healthcare Conference being held December 1-3, 2026, in New York City. David Hochman, Chairman and Chief Executive Officer, will participate in a fireside chat hosted by Matthew O\u2019Brien, Managing Director, Senior Research Analyst at Piper Sandler on Wednesday, Dec. 2, 2026, at 9:00am ET. Management will also host one-on-one meetings with investors during the event. A live webcast of the event will be accessible through Orchestra BioMed\u2019s Investor Relations website &hellip; Continue reading &quot;Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-17T17:13:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3ODUyOSM3OTY4MjM5IzIxOTQwMTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference\",\"datePublished\":\"2026-11-17T17:13:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/\"},\"wordCount\":470,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3ODUyOSM3OTY4MjM5IzIxOTQwMTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/\",\"name\":\"Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3ODUyOSM3OTY4MjM5IzIxOTQwMTk=\",\"datePublished\":\"2026-11-17T17:13:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3ODUyOSM3OTY4MjM5IzIxOTQwMTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3ODUyOSM3OTY4MjM5IzIxOTQwMTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference - Market Newsdesk","og_description":"NEW HOPE, Pa., Nov. 17, 2026 (GLOBE NEWSWIRE) &#8212; Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (\u201cOrchestra BioMed\u201d or the \u201cCompany\u201d), a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companies, today announced that management will participate in the Piper Sandler 38th Annual Healthcare Conference being held December 1-3, 2026, in New York City. David Hochman, Chairman and Chief Executive Officer, will participate in a fireside chat hosted by Matthew O\u2019Brien, Managing Director, Senior Research Analyst at Piper Sandler on Wednesday, Dec. 2, 2026, at 9:00am ET. Management will also host one-on-one meetings with investors during the event. A live webcast of the event will be accessible through Orchestra BioMed\u2019s Investor Relations website &hellip; Continue reading \"Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-17T17:13:53+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3ODUyOSM3OTY4MjM5IzIxOTQwMTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference","datePublished":"2026-11-17T17:13:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/"},"wordCount":470,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3ODUyOSM3OTY4MjM5IzIxOTQwMTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/","name":"Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3ODUyOSM3OTY4MjM5IzIxOTQwMTk=","datePublished":"2026-11-17T17:13:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3ODUyOSM3OTY4MjM5IzIxOTQwMTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3ODUyOSM3OTY4MjM5IzIxOTQwMTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchestra-biomed-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1021841","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1021841"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1021841\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1021841"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1021841"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1021841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}